135 related articles for article (PubMed ID: 11939684)
1. Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresis.
Willey ML; de Denus S; Spinler SA
Pharmacotherapy; 2002 Apr; 22(4):492-9. PubMed ID: 11939684
[TBL] [Abstract][Full Text] [Related]
2. Hirudin elimination by hemofiltration: a comparative in vitro study of different membranes.
Frank RD; Farber H; Stefanidis I; Lanzmich R; Kierdorf HP
Kidney Int Suppl; 1999 Nov; (72):S41-5. PubMed ID: 10560804
[TBL] [Abstract][Full Text] [Related]
3. The use of ecarin chromogenic assay and prothrombinase induced clotting time in the monitoring of lepirudin for the treatment of heparin-induced thrombocytopenia.
Guy S; Kitchen S; Laidlaw S; Cooper P; Woolley A; Maclean R
Br J Haematol; 2008 Jul; 142(3):466-8. PubMed ID: 18510685
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial.
Beiderlinden M; Werner P; Bahlmann A; Kemper J; Brezina T; Schäfer M; Görlinger K; Seidel H; Kienbaum P; Treschan TA
BMC Anesthesiol; 2018 Feb; 18(1):18. PubMed ID: 29426286
[TBL] [Abstract][Full Text] [Related]
5. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis.
Fischer KG; van de Loo A; Böhler J
Kidney Int Suppl; 1999 Nov; (72):S46-50. PubMed ID: 10560805
[TBL] [Abstract][Full Text] [Related]
6. Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis.
Dager WE; White RH
Ann Pharmacother; 2001; 35(7-8):885-90. PubMed ID: 11485140
[TBL] [Abstract][Full Text] [Related]
7. Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: assessment of different filter systems.
Koster A; Merkle F; Hansen R; Loebe M; Kuppe H; Hetzer R; Crystal GJ; Mertzlufft F
Anesth Analg; 2000 Aug; 91(2):265-9. PubMed ID: 10910829
[TBL] [Abstract][Full Text] [Related]
8. Hemofiltration of recombinant hirudin by different hemodialyzer membranes: implications for clinical use.
Benz K; Nauck MA; Böhler J; Fischer KG
Clin J Am Soc Nephrol; 2007 May; 2(3):470-6. PubMed ID: 17699453
[TBL] [Abstract][Full Text] [Related]
9. Hirudin in heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
[TBL] [Abstract][Full Text] [Related]
10. [Removal of lepirudin used as an anticoagulant in mechanical autotransfusion with Cell-Saver 5].
Marx A; von Lüpke U; Tessmann R; Lindhoff-Last E
Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Mar; 36(3):162-6. PubMed ID: 11324348
[TBL] [Abstract][Full Text] [Related]
11. Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot study.
Riess FC; Poetzsch B; Madlener K; Cramer E; Doll KN; Doll S; Lorke DE; Kormann J; Mueller-Berghaus G
Thorac Cardiovasc Surg; 2007 Jun; 55(4):233-8. PubMed ID: 17546553
[TBL] [Abstract][Full Text] [Related]
12. Lepirudin in the management of heparin-induced thrombocytopenia.
Gajra A; Husain J; Smith A
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1131-41. PubMed ID: 18680447
[TBL] [Abstract][Full Text] [Related]
13. Hirudin in renal insufficiency.
Fischer KG
Semin Thromb Hemost; 2002 Oct; 28(5):467-82. PubMed ID: 12420243
[TBL] [Abstract][Full Text] [Related]
14. [Lepirudin during cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia].
Boinot C; Lanquetot H; Macchi L; Charrière JM; Menu P
Ann Fr Anesth Reanim; 2003 Jul; 22(7):635-8. PubMed ID: 12946496
[TBL] [Abstract][Full Text] [Related]
15. Lepirudin dosing in dialysis-dependent renal failure.
Wittkowsky AK; Kondo LM
Pharmacotherapy; 2000 Sep; 20(9):1123-8. PubMed ID: 10999507
[TBL] [Abstract][Full Text] [Related]
16. Lepirudin for anticoagulation in patients with heparin-induced thrombocytopenia treated with continuous renal replacement therapy.
Gajra A; Vajpayee N; Smith A; Poiesz BJ; Narsipur S
Am J Hematol; 2007 May; 82(5):391-3. PubMed ID: 17109386
[TBL] [Abstract][Full Text] [Related]
17. Immunoassays in monitoring biotechnological drugs.
Gygax D; Botta L; Ehrat M; Graf P; Lefèvre G; Oroszlan P; Pfister C
Ther Drug Monit; 1996 Aug; 18(4):405-9. PubMed ID: 8857560
[TBL] [Abstract][Full Text] [Related]
18. Recombinant hirudin in clinical practice: focus on lepirudin.
Greinacher A; Lubenow N
Circulation; 2001 Mar; 103(10):1479-84. PubMed ID: 11245656
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic studies with recombinant hirudin in dogs.
Nowak G; Markwardt F; Fink E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):70-4. PubMed ID: 2459035
[TBL] [Abstract][Full Text] [Related]
20. Salvage late plasmapheresis in a patient with pulmonary embolism caused by heparin-induced thrombocytopenia primarily resistant to danaparoid sodium and lepirudin.
Antonijevic NM; Savic NB; Perunicic J; Kovac M; Mikovic D; Stanojevic M; Calija B; Milosevic RA; Obradovic SD; Vasiljevic Z
J Clin Apher; 2006 Dec; 21(4):252-5. PubMed ID: 16933276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
